Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma.
Kamezaki K, Kikushige Y, Numata A, Miyamoto T, Takase K, Henzan H, Aoki K, Kato K, Nonami A, Kamimura T, Arima F, Takenaka K, Harada N, Fukuda T, Hayashi S, Ohno Y, Eto T, Harada M, Nagafuji K. Kamezaki K, et al. Among authors: fukuda t. Bone Marrow Transplant. 2007 May;39(9):523-7. doi: 10.1038/sj.bmt.1705649. Epub 2007 Mar 19. Bone Marrow Transplant. 2007. PMID: 17369863 Clinical Trial.
Autoimmune thrombocytopenia with clonal expansion of CD8-positive T cells after autologous peripheral blood stem cell transplantation for diffuse large B-cell lymphoma.
Isobe T, Tanimoto TE, Nakaji G, Miyamoto T, Yamasaki S, Takase K, Numata A, Fukuda T, Nagafuji K, Inaba S, Harada M. Isobe T, et al. Among authors: fukuda t. Bone Marrow Transplant. 2005 Feb;35(3):315-6. doi: 10.1038/sj.bmt.1704750. Bone Marrow Transplant. 2005. PMID: 15568035 No abstract available.
Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.
Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, Takase K, Henzan H, Kato K, Takenaka K, Fukuda T, Harada N, Nagafuji K, Teshima T, Akashi K, Harada M, Eto T; Fukuoka Blood and Marrow Transplantation Group. Numata A, et al. Among authors: fukuda t. Bone Marrow Transplant. 2010 Feb;45(2):311-6. doi: 10.1038/bmt.2009.165. Epub 2009 Jul 13. Bone Marrow Transplant. 2010. PMID: 19597416
Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma.
Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y, Fukuda T, Hidaka M, Moriuchi Y, Miyamoto T, Uike N, Taguchi J, Eto T, Tomoyose T, Kondo T, Yamanoha A, Ichinohe T, Atsuta Y, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Fuji S, et al. Among authors: fukuda t. Bone Marrow Transplant. 2016 Feb;51(2):205-11. doi: 10.1038/bmt.2015.265. Epub 2015 Nov 2. Bone Marrow Transplant. 2016. PMID: 26524263 Clinical Trial.
Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation.
Itonaga H, Ishiyama K, Aoki K, Aoki J, Ishikawa T, Ohashi K, Fukuda T, Ozawa Y, Ota S, Uchida N, Eto T, Iwato K, Ohno Y, Takanashi M, Ichinohe T, Atsuta Y, Miyazaki Y. Itonaga H, et al. Among authors: fukuda t. Bone Marrow Transplant. 2019 Sep;54(9):1471-1481. doi: 10.1038/s41409-019-0469-5. Epub 2019 Feb 4. Bone Marrow Transplant. 2019. PMID: 30718803 Clinical Trial.
Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT.
Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J. Nishiwaki S, et al. Among authors: fukuda t. Bone Marrow Transplant. 2016 Jan;51(1):43-50. doi: 10.1038/bmt.2015.217. Epub 2015 Sep 21. Bone Marrow Transplant. 2016. PMID: 26389833 Clinical Trial.
4,968 results